H Kahal1, A Aburima2, B Spurgeon2, K S Wraith2, A S Rigby2, T Sathyapalan3, E S Kilpatrick4, K M Naseem5, S L Atkin6. 1. Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK; Centre for Cardiovascular and Metabolic Research, Hull York Medical School, Hull, UK. 2. Centre for Cardiovascular and Metabolic Research, Hull York Medical School, Hull, UK. 3. Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK. 4. Sidra Medical Research Centre, Doha, Qatar. 5. Leeds Institute of Genetics, Health and Therapeutics (LIGHT), University of Leeds, Leeds, UK. 6. Weill Cornell Medical College Qatar, PO Box 24144, Doha, Qatar. Electronic address: sla2002@qatar-med.cornell.edu.
Abstract
AIM: Strict glycaemic control has been associated with an increased mortality rate in subjects with type 2 diabetes (T2DM). Here we examined platelet function immediately and 24hours following induced hypoglycaemia in people with type 2 diabetes compared to healthy age-matched controls. METHODS: Hyperinsulinaemic clamps reduced blood glucose to 2.8mmol/L (50mg/dl) for 1hour. Sampling at baseline; euglycaemia 5mmol/L (90mg/dl); hypoglycaemia; and at 24 post clamp were undertaken. Platelet function was measured by whole blood flow cytometry. RESULTS: 10 subjects with T2DM and 8 controls were recruited. Platelets from people with T2DM showed reduced sensitivity to prostacyclin (PGI2, 1nM) following hypoglycaemia. The ability of PGI2 to inhibit platelet activation was significantly impaired at 24hours compared to baseline in the T2DM group. Here, inhibition of fibrinogen binding was 29.5% (10.3-43.8) compared to 50.8% (36.8-61.1), (P<0.05), while inhibition of P-selectin expression was 32% (16.1-47.6) vs. 54.4% (42.5-67.5) (P<0.05). No significant changes in platelet function were noted in controls. CONCLUSION: Induced hypoglycaemia in T2DM enhances platelet hyperactivity through impaired sensitivity to prostacyclin at 24hours.
AIM: Strict glycaemic control has been associated with an increased mortality rate in subjects with type 2 diabetes (T2DM). Here we examined platelet function immediately and 24hours following induced hypoglycaemia in people with type 2 diabetes compared to healthy age-matched controls. METHODS:Hyperinsulinaemic clamps reduced blood glucose to 2.8mmol/L (50mg/dl) for 1hour. Sampling at baseline; euglycaemia 5mmol/L (90mg/dl); hypoglycaemia; and at 24 post clamp were undertaken. Platelet function was measured by whole blood flow cytometry. RESULTS: 10 subjects with T2DM and 8 controls were recruited. Platelets from people with T2DM showed reduced sensitivity to prostacyclin (PGI2, 1nM) following hypoglycaemia. The ability of PGI2 to inhibit platelet activation was significantly impaired at 24hours compared to baseline in the T2DM group. Here, inhibition of fibrinogen binding was 29.5% (10.3-43.8) compared to 50.8% (36.8-61.1), (P<0.05), while inhibition of P-selectin expression was 32% (16.1-47.6) vs. 54.4% (42.5-67.5) (P<0.05). No significant changes in platelet function were noted in controls. CONCLUSION: Induced hypoglycaemia in T2DM enhances platelet hyperactivity through impaired sensitivity to prostacyclin at 24hours.
Authors: Felix Aberer; Peter N Pferschy; Norbert J Tripolt; Caren Sourij; Anna M Obermayer; Florian Prüller; Eva Novak; Philipp Reitbauer; Harald Kojzar; Barbara Prietl; Selina Kofler; Martina Brunner; Eva Svehlikova; Tatjana Stojakovic; Hubert Scharnagl; Abderrahim Oulhaj; Faisal Aziz; Regina Riedl; Harald Sourij Journal: Diabetes Obes Metab Date: 2019-11-03 Impact factor: 6.577
Authors: Annunziata Nusca; Dario Tuccinardi; Claudio Proscia; Rosetta Melfi; Silvia Manfrini; Antonio Nicolucci; Antonio Ceriello; Paolo Pozzilli; Gian Paolo Ussia; Francesco Grigioni; Germano Di Sciascio Journal: Cardiovasc Diabetol Date: 2019-11-09 Impact factor: 9.951
Authors: Abu Saleh Md Moin; Manjula Nandakumar; Hassan Kahal; Thozhukat Sathyapalan; Stephen L Atkin; Alexandra E Butler Journal: Cells Date: 2021-11-10 Impact factor: 6.600
Authors: Manjunath Ramanjaneya; Ruth Priyanka; Milin Bensila; Jayakumar Jerobin; Krunal Pawar; Thozhukat Sathyapalan; Abdul Badi Abou-Samra; Najeeb M Halabi; Abu Saleh Md Moin; Stephen L Atkin; Alexandra E Butler Journal: Front Endocrinol (Lausanne) Date: 2022-08-09 Impact factor: 6.055
Authors: Abu Saleh Md Moin; Thozhukat Sathyapalan; Stephen L Atkin; Alexandra E Butler Journal: Cardiovasc Diabetol Date: 2022-10-06 Impact factor: 8.949
Authors: Hassan Kahal; Anna Halama; Ahmed Aburima; Aditya M Bhagwat; Alexandra E Butler; Johannes Graumann; Karsten Suhre; Thozhukat Sathyapalan; Stephen L Atkin Journal: Sci Rep Date: 2020-03-16 Impact factor: 4.379
Authors: Abu Saleh Md Moin; Ahmed Al-Qaissi; Thozhukat Sathyapalan; Stephen L Atkin; Alexandra E Butler Journal: Front Endocrinol (Lausanne) Date: 2021-06-25 Impact factor: 5.555